Published in Biochim Biophys Acta on December 23, 1993
Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer (2006) 2.16
Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc Natl Acad Sci U S A (1998) 1.41
Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH. J Virol (2005) 1.13
Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest. J Virol (2001) 1.12
Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7. Biochem J (1996) 1.07
USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity. J Biol Chem (2008) 0.89
NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity. J Virol (2010) 0.83
Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice. BMC Cancer (2008) 0.82
HPV16 E7-dependent transformation activates NHE1 through a PKA-RhoA-induced inhibition of p38alpha. PLoS One (2008) 0.80
Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix. J Clin Pathol (1997) 0.77
Differential gene expression between skin and cervix induced by the E7 oncoprotein in a transgenic mouse model. Virology (2012) 0.76
Phosphorylation of the bovine papillomavirus E2 protein on tyrosine regulates its transcription and replication functions. J Virol (2016) 0.75
Mutagenic Potential ofBos taurus Papillomavirus Type 1 E6 Recombinant Protein: First Description. Biomed Res Int (2015) 0.75
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A (1999) 7.60
Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature (1987) 5.61
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet (1999) 5.09
Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science (1990) 4.92
The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet (1997) 4.86
SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet (1998) 3.51
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet (2000) 3.41
Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus. Science (1985) 3.21
Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J (1987) 2.84
Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci U S A (2000) 2.72
The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer. EMBO J (1988) 2.66
Bovine papilloma virus-transformed cells contain multiple E2 proteins. Proc Natl Acad Sci U S A (1988) 2.29
Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science (1995) 2.20
Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J Virol (1999) 2.09
Identification of bovine papillomavirus E1 mutants with increased transforming and transcriptional activity. J Virol (1989) 1.64
Amino acids necessary for DNA contact and dimerization imply novel motifs in the papillomavirus E2 trans-activator. Genes Dev (1992) 1.49
Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J (1993) 1.49
Proteins encoded by the bovine papillomavirus E1 open reading frame: expression in heterologous systems and in virally transformed cells. J Virol (1990) 1.49
Identification of an alpha helical motif sufficient for association with papillomavirus E6. J Biol Chem (1998) 1.45
The SWI/SNF chromatin remodeling subunit BRG1 is a critical regulator of p53 necessary for proliferation of malignant cells. Oncogene (2009) 1.45
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther (2001) 1.37
The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum Mol Genet (1998) 1.35
Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences. J Virol (1991) 1.32
AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J Virol (2000) 1.30
Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding. J Virol (1992) 1.29
Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J (1990) 1.27
Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J Virol (1996) 1.24
Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain. Mol Cell Biol (1997) 1.24
Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism. J Mol Biol (1998) 1.23
Identification of survival motor neuron as a transcriptional activator-binding protein. Hum Mol Genet (1999) 1.22
X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol (1985) 1.21
The exon 2b region of the spinal muscular atrophy protein, SMN, is involved in self-association and SIP1 binding. Hum Mol Genet (2000) 1.21
Trans activation by the bovine papillomavirus E2 protein in Saccharomyces cerevisiae. J Virol (1989) 1.18
Genetic analysis of the bovine papillomavirus E2 transcriptional activation domain. Virology (1996) 1.15
Transcriptional activation function is not required for stimulation of DNA replication by bovine papillomavirus type 1 E2. J Virol (1996) 1.14
Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB. J Virol (1998) 1.08
Mutational analysis of bovine papillomavirus E6 gene. J Virol (1989) 1.05
AMF1 (GPS2) modulates p53 transactivation. Mol Cell Biol (2001) 1.02
Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry (2001) 1.01
hAda3 regulates p14ARF-induced p53 acetylation and senescence. Oncogene (2007) 0.99
The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain. Oncogene (1995) 0.98
Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor. DNA Cell Biol (1994) 0.98
Human papillomavirus type 16 E6-enhanced susceptibility of L929 cells to tumor necrosis factor alpha correlates with increased accumulation of reactive oxygen species. J Biol Chem (1999) 0.94
Regulation of murine survival motor neuron (Smn) protein levels by modifying Smn exon 7 splicing. Hum Mol Genet (2001) 0.94
A novel method for selective isotope labeling of bacterially expressed proteins. J Biomol NMR (1995) 0.92
Structural correlates for enhanced stability in the E2 DNA-binding domain from bovine papillomavirus. Biochemistry (1999) 0.90
The tryptophan bridge is a critical feature of the papillomavirus E2 DNA binding domain. Virology (1993) 0.88
The BPV-1 E2 DNA-contact helix cysteine is required for transcriptional activation but not replication in mammalian cells. Virology (1996) 0.88
Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6. Virology (1997) 0.86
Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol (1984) 0.84
Papillomaviruses and interferon. Ciba Found Symp (1986) 0.83
Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg (1991) 0.82
Increased ouabain-sensitive glycolysis of lymphocytes treated with phytohemagglutinin: relationship to potassium transport. J Cell Physiol (1978) 0.81
Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol (1990) 0.81
Sequences flanking the core DNA-binding domain of bovine papillomavirus type 1 E2 contribute to DNA-binding function. J Virol (1997) 0.80
Two distinct regions of the BPV1 E1 replication protein interact with the activation domain of E2. Virus Res (1999) 0.80
1H, 15N, and 13C NMR resonance assignments for the DNA-binding domain of the BPV-1 E2 protein. J Biomol NMR (1998) 0.80
Papillomavirus-associated inductions of cellular proteins in mouse C127 cells: correlation with the presence of open reading frame E2. Virology (1989) 0.79
Polyomavirus large T can support DNA replication in human cells. Virology (1998) 0.78
Rb-independent induction of apoptosis by bovine papillomavirus type 1 E7 in response to tumor necrosis factor alpha. J Biol Chem (2000) 0.77
The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis. Oncogene (1999) 0.77
Isolation, sequence analysis and characterization of a cDNA encoding human chaperonin 10. Biochim Biophys Acta (1994) 0.76
Assignment of the gene for ERC-55 (RCN2) to human chromosome band 15q22.33-->q24.1 by in situ hybridization. Cytogenet Cell Genet (1997) 0.75
UV-B-energy distribution in phototherapy equipment. Arch Dermatol (1984) 0.75
Tumor viruses, oncogenes, and human cancer. J Am Acad Dermatol (1984) 0.75